Pfizer Management

Management criteria checks 3/4

Pfizer's CEO is Albert Bourla, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is $21.56M, comprised of 8.3% salary and 91.7% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth $8.39M. The average tenure of the management team and the board of directors is 5.9 years and 7.8 years respectively.

Key information

Albert Bourla

Chief executive officer

US$21.6m

Total compensation

CEO salary percentage8.3%
CEO tenure5.9yrs
CEO ownership0.006%
Management average tenure5.9yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Albert Bourla's remuneration changed compared to Pfizer's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 29 2024n/an/a

US$4b

Jun 30 2024n/an/a

-US$3b

Mar 31 2024n/an/a

-US$288m

Dec 31 2023US$22mUS$2m

US$2b

Oct 01 2023n/an/a

US$10b

Jul 02 2023n/an/a

US$21b

Apr 02 2023n/an/a

US$29b

Dec 31 2022US$33mUS$2m

US$31b

Oct 02 2022n/an/a

US$30b

Jul 03 2022n/an/a

US$29b

Apr 03 2022n/an/a

US$25b

Dec 31 2021US$24mUS$2m

US$22b

Oct 03 2021n/an/a

US$19b

Jul 04 2021n/an/a

US$12b

Apr 04 2021n/an/a

US$9b

Dec 31 2020US$21mUS$2m

US$7b

Sep 27 2020n/an/a

US$212m

Jun 28 2020n/an/a

US$7b

Mar 29 2020n/an/a

US$9b

Dec 31 2019US$18mUS$2m

US$11b

Sep 29 2019n/an/a

US$16b

Jun 30 2019n/an/a

US$13b

Mar 31 2019n/an/a

US$11b

Dec 31 2018US$10mUS$1m

US$4b

Sep 30 2018n/an/a

US$24b

Jul 01 2018n/an/a

US$23b

Apr 01 2018n/an/a

US$22b

Dec 31 2017US$9mUS$1m

US$21b

Compensation vs Market: Albert's total compensation ($USD21.56M) is above average for companies of similar size in the UK market ($USD5.85M).

Compensation vs Earnings: Albert's compensation has been consistent with company performance over the past year.


CEO

Albert Bourla (62 yo)

5.9yrs

Tenure

US$21,562,064

Compensation

Dr. Albert Bourla, DVM, Ph.D. serves as the Chief Executive Officer of Pfizer Inc. since January 1, 2019 and serves as its Chairman and director of the Board since January 2020 and had been its Executive D...


Leadership Team

NamePositionTenureCompensationOwnership
Albert Bourla
Chairman of the Board & CEO5.9yrsUS$21.56m0.0059%
$ 8.4m
David Denton
Chief Financial Officer & Executive VP2.6yrsUS$5.28m0.00067%
$ 958.0k
Mikael Dolsten
Chief Scientific Officer and President of Research & Development5.9yrsUS$8.86m0.0057%
$ 8.2m
Douglas Lankler
Executive VP & General Counsel11yrsUS$5.48m0.0026%
$ 3.7m
Jennifer Damico
Senior VP4.8yrsno data0.00015%
$ 214.5k
Lidia Fonseca
Executive VP and Chief Digital & Technology Officer5.9yrsno datano data
Francesca DeMartino
Chief Investor Relations Officerno datano datano data
Rady Johnson
Executive VP and Chief Compliance11yrsno data0.0018%
$ 2.6m
Andreas Panayiotou
Global Chief Marketing Officer2.3yrsno datano data
Payal Becher
Chief People Experience Officer & Executive VP4.5yrsno data0.00063%
$ 900.8k
Sally Susman
Executive VP & Chief Corporate Affairs Officer16.8yrsno data0.0029%
$ 4.1m
Annette Doherty
Head of Worldwide Pharmaceutical Sciences19.6yrsno datano data

5.9yrs

Average Tenure

59yo

Average Age

Experienced Management: 0Q1N's management team is seasoned and experienced (5.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Albert Bourla
Chairman of the Board & CEO4.9yrsUS$21.56m0.0059%
$ 8.4m
Shantanu Narayen
Lead Independent Director11.3yrsUS$430.00kno data
Ronald Blaylock
Independent Director7.8yrsUS$380.00k0.00023%
$ 328.8k
Suzanne Nora Johnson
Independent Director17.3yrsUS$410.00k0.00018%
$ 257.4k
James Smith
Independent Director10.5yrsUS$390.00k0.000060%
$ 85.8k
Charles Hagel
Member of Emerging Markets Advisory Boardno datano datano data
Susan Hockfield
Independent Director4.8yrsUS$363.00kno data
Daniel Littman
Independent Director6.8yrsUS$391.40kno data
James Robert Quincey
Independent Director4.8yrsUS$380.00kno data
Scott Gottlieb
Independent Director5.5yrsUS$417.20k0.00018%
$ 257.4k
Joseph Echevarria
Independent Director9.5yrsUS$390.00kno data
Helen Hobbs
Independent Director13yrsUS$410.00kno data

7.8yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 0Q1N's board of directors are considered experienced (7.8 years average tenure).